Glenmark Pharma
Beyond generics: Glenmark resets agenda with a bold 10-year pivot to global drug innovation, says chairman Saldanha
For chairman Glenn Saldanha, the way forward is a mix of licensing deals, partnerships and Glenmark’s own commercialization in emerging markets.
5 min read7 Jul 2026After a dull Q4, Glenmark Pharma needs a booster shot to grow
Investors are shifting their focus to core operational execution as the drugmaker looks past one-off licensing gains to drive its FY27 growth.
2 min read2 Jun 2026Mphasis to Glenmark - Jay Thakkar suggests 3 stocks to buy or sell for short-term in F&O segment
The Indian stock market is set to open lower, with the Gift Nifty at 23,882, down 97 points. Benchmark indices fell on profit-taking and rising crude oil prices, leading to cautious sentiment. Nifty 50 faces immediate hurdles at 24,100 and support at 23,800.
4 min read27 May 2026Rajesh Palviya of Axis Sec suggests Glenmark Pharma, Polycab India, Karnataka Bank shares to buy today
Domestic indices Nifty 50 and Sensex opened lower due to declines in financial stocks amid rising tensions in the US-Israeli conflict. Nifty dropped 0.44% while Sensex fell 0.45%. Brent crude surged nearly 5%, raising inflation concerns and obscuring global growth outlook.
3 min read6 Mar 2026Stocks to buy for short term: Axis Securities' three stock picks for up to 22% returns in a tough week for D-Street
Among Axis Securities' stocks to buy are: Glenmark Pharma, Tube Investments and Chennai Petroleum. The brokerage expects up to 22% upside in these stocks over 3-4 weeks.
2 min read3 Mar 2026Stocks to buy today: From Glenmark to BPCL— Sagar Doshi lists 3 stocks, spotting favourable technical setup
Nifty reclaimed its 26000 mark in its last weekly closing negating its short term downside which had opened up at the start of previous week. The index has got back into a short term buy on dip zone for a targets of 26250 / 26450 once again.
2 min read17 Dec 2025Glenmark Pharmaceuticals board declares ₹2.50 per share interim dividend for FY26
Glenmark Pharmaceuticals announced an interim dividend of ₹2.50 per share for FY26, with a record date set for October 3, 2025.
2 min read26 Sep 2025Glenmark inks $18 million deal for cancer drug with China’s Hengrui
The deal involves an upfront payment of $18 million, followed by regulatory and commercial milestone payments of up to $1.093 billion, as well as royalties.
2 min read24 Sep 2025Glenmark, Indraprastha Gas among 7 key companies to trade ex-dividend today, 15 September 2025
Dividend Stocks 2025: Glenmark, IGL (Indraprastha Gas Ltd) , Aarti Pharmalabs, KNR Constructions, Texmaco Rail & Engineering Ltd., Power Mech Projects, DOMS Industries and Landmark Cars Ltd are among 7 key companies that will trade ex dividend on 15 September 2025
1 min read15 Sep 2025Industrial evolution: Indian pharma needs a major R&D-oriented reset
Glenmark’s progress with a cancer treatment shows the potential of Indian pharma to move from generics to drug discovery. With tech-enabled therapies evolving fast, new inflection points spell a variety of opportunities for startups and established players to leap ahead.
2 min read14 Jul 2025Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.